Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 11 10 2022
medline: 3 7 2023
pubmed: 18 1 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

Cold hemodialysis (HD) prevented intradialysis hypotension (IDH) in small, short-term, randomized trials in selected patients with IDH. Whether this treatments prevents IDH and mortality in the HD population at large is unknown. We investigated the relationship between dialysate temperature and the risk of IDH, i.e. nadir blood pressure <90 mmHg (generalized estimating equation model) and all-cause mortality (Cox's regression) in an incident cohort of HD patients (n = 8071). To control for confounding by bias by indication and other factors we applied instrumental variables adjusting for case mix at facility level. Twenty-seven percent of patients in the study cohort were systematically treated with a dialysate temperature ≤35.5°C. Over a median follow-up of 13.6 months (interquartile range 5.2-26.1 months), a 0.5°C reduction of the dialysate temperature was associated with a small (-2.4%) reduction of the risk of IDH [odds ratio (OR) 0.976, 95% confidence interval (CI) 0.957-0.995, P = .013]. In case-mix, facility-level adjusted analysis, the association became much stronger (OR 0.67, 95% CI 0.63-0.72, risk reduction = 33%, P < .001). In contrast, colder dialysate temperature had no effect on mortality both in the unadjusted [hazard ratio (HR) (0.5°C decrease) 1.074, 95% CI 0.972-1.187, P = .16] and case-mix-adjusted analysis at facility level (HR 1.01, 95% CI 0.88-1.16, P = .84). Similar results were registered in additional analyses by instrumental variables applying the median dialysate temperature or the facility percentage of patients prescribed a dialysate temperature <36°C. Further analyses restricted to patients with recurrent IDH fully confirmed these findings. Cold HD was associated with IDH in the HD population but had no association with all-cause mortality.

Sections du résumé

BACKGROUND BACKGROUND
Cold hemodialysis (HD) prevented intradialysis hypotension (IDH) in small, short-term, randomized trials in selected patients with IDH. Whether this treatments prevents IDH and mortality in the HD population at large is unknown.
METHODS METHODS
We investigated the relationship between dialysate temperature and the risk of IDH, i.e. nadir blood pressure <90 mmHg (generalized estimating equation model) and all-cause mortality (Cox's regression) in an incident cohort of HD patients (n = 8071). To control for confounding by bias by indication and other factors we applied instrumental variables adjusting for case mix at facility level.
RESULTS RESULTS
Twenty-seven percent of patients in the study cohort were systematically treated with a dialysate temperature ≤35.5°C. Over a median follow-up of 13.6 months (interquartile range 5.2-26.1 months), a 0.5°C reduction of the dialysate temperature was associated with a small (-2.4%) reduction of the risk of IDH [odds ratio (OR) 0.976, 95% confidence interval (CI) 0.957-0.995, P = .013]. In case-mix, facility-level adjusted analysis, the association became much stronger (OR 0.67, 95% CI 0.63-0.72, risk reduction = 33%, P < .001). In contrast, colder dialysate temperature had no effect on mortality both in the unadjusted [hazard ratio (HR) (0.5°C decrease) 1.074, 95% CI 0.972-1.187, P = .16] and case-mix-adjusted analysis at facility level (HR 1.01, 95% CI 0.88-1.16, P = .84). Similar results were registered in additional analyses by instrumental variables applying the median dialysate temperature or the facility percentage of patients prescribed a dialysate temperature <36°C. Further analyses restricted to patients with recurrent IDH fully confirmed these findings.
CONCLUSIONS CONCLUSIONS
Cold HD was associated with IDH in the HD population but had no association with all-cause mortality.

Identifiants

pubmed: 36649682
pii: 6989848
doi: 10.1093/ndt/gfad003
doi:

Substances chimiques

Dialysis Solutions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1700-1706

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.

Auteurs

Carmine Zoccali (C)

Renal Research Institute NY, USA; Institute of Biology and Molecular Genetics (BIOGEM), Ariano Irpino, Italy and Associazione Ipertensione Nefrologia e Trapianto Renale (IPNET), Reggio Calabria, Italy.

Giovanni Tripepi (G)

Clinical Epidemiology of Renal Diseases and Hypertension Unit, Consiglio Nazionale delle Ricerche (CNR) Institute of Clinical Physiology, Reggio Calabria, Italy.

Luca Neri (L)

Fresenius Medical Care Europe, Middle East and Africa (EMEA, Homburg).

Matteo Savoia (M)

Fresenius Medical Care Europe, Middle East and Africa (EMEA, Homburg).

Maria Eva Baró Salvador (ME)

Fresenius Medical Care Europe, Middle East and Africa (EMEA, Homburg).

Pedro Ponce (P)

Fresenius Medical Care Europe, Middle East and Africa (EMEA, Homburg).

Jeffrey Hymes (J)

Fresenius Medical Care, Waltham, MA, USA plus Fresenius Medical Care, Homburg, Germany.

Frank Maddux (F)

Fresenius Medical Care, Waltham, MA, USA plus Fresenius Medical Care, Homburg, Germany.

Francesca Mallamaci (F)

Clinical Epidemiology of Renal Diseases and Hypertension Unit, Consiglio Nazionale delle Ricerche (CNR) Institute of Clinical Physiology, Reggio Calabria, Italy.
Unità di Nefrologia Dialisi e Trapianto Renale, Grande Ospedale Metropolitano, Reggio Calabria, Italy.

Stefano Stuard (S)

Fresenius Medical Care Europe, Middle East and Africa (EMEA, Homburg).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH